EXPLANATORY NOTE
This Schedule 13G/A is being filed as an amendment (Amendment No. 2) to the statement on Schedule 13G filed with the Securities and Exchange
Commission (SEC) on behalf of the Reporting Persons identified below, with respect to the Class A common stock of Hims & Hers Health, Inc. (the Class A Common Stock) on February 14, 2020, as amended by
the amendment on Schedule 13G/A filed on February 19, 2020 (as amended, the Schedule 13G), pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, to amend and supplement
certain information set forth below in the items indicated. All capitalized terms used in this Amendment No. 2 and not otherwise defined herein have the meanings ascribed to such terms in the Schedule 13G.
The Reporting Persons are filing this Amendment No. 2 to report (i) changes to the Schedule 13G, (ii) the distribution of shares of
Class A Common Stock by Oaktree Acquisition Holdings, L.P. on a pro rata basis to its members or their permitted transferees, including to General Partner, Management, Management GP, Atlas, OCGH GP, BAM and Partners, and (iii) that the
Reporting Persons ceased to beneficially own more than five percent of the class of common stock.
Hims & Hers Health, Inc. (the Issuer). On January 20, 2021, Oaktree Acquisition Corp., a Cayman Islands exempted
company (OAC), consummated the transaction contemplated by that certain Agreement and Plan of Merger, dated September 30, 2020 (the Merger), domesticated as Delaware corporation (the Domestication and,
together with the Merger, the Business Combination) and changed its name to Hims & Hers Health, Inc.
Item 1(b)
|
Address of the Issuers Principal Executive Offices
|
2269 Chestnut Street, #523, San Francisco, California 94123.
Item 2(d)
|
Title of Class of Securities
|
Class A Common Stock, $0.0001 par value per share. As a result of an upon the effective time of the Domestication, each of the then issued
and outstanding Class A ordinary shares, par value $0.0001 per share, of OAC (the Class A Ordinary Shares) automatically converted, on a
one-for-one basis, into shares of Class A Common Stock.
433000 106
The responses to Items 5 to 9 and 11 in each of the cover pages of this Schedule 13G are incorporated herein by reference.
The Reporting Persons own an aggregate of 6,785,937 shares of the Issuers Class A Common Stock, consisting of 3,773,437 shares of
Class A Common Stock and 3,012,500 warrants to acquire one share of Class A Common Stock (the Warrants), representing approximately 3.7% of the total Class A Common Stock issued and outstanding. In connection with the
Business Combination, Sponsor forfeited 1,004,167 of its warrants to acquire Class A Ordinary Shares. As a result of an upon the effective time of the Domestication, each of the then issued and outstanding Class A Ordinary Shares
automatically converted, on a one-for-one basis, into a share of Class A Common Stock. Upon consummation of the Business Combination, all outstanding Warrants
became exercisable. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the
beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
10